If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today

·4 min read
If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today

CRISPR Therapeutics (NASDAQ: CRSP) is one of the most exciting biotechs on the market today, because it's pushing the limits of what is possible when it comes to treating hereditary diseases. As the flagship program, it's not an exaggeration to say that CRISPR's success was in large part riding on CTX001, so the stock would have been ripe for speculators -- and it still is.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting